Traumatic brain injury (TBI) is an important cause of disability in humans. Neuroactive steroids, such as progesterone and dehydroepiandrosterone (DHEA), are neuroprotective in TBI models. However in order to design potential neuroprotective strategies based on neuroactive steroids it is important to determine whether its brain levels are altered by TBI. In this study we have used a weight-drop model of TBI in young adult female mice to determine the levels of neuroactive steroids in the brain and plasma at 24. h, 72. h and 2 weeks after injury. We have also analyzed whether the levels of neuroactive steroids after TBI correlated with the neurological score of the animals. TBI caused neurological deficit detectable at 24 and 72. h, which recovered by 2 weeks after injury. Brain levels of progesterone, tetrahydroprogesterone (THP), isopregnanolone and 17β-estradiol were decreased 24. h, 72. h and 2 weeks after TBI. DHEA and brain testosterone levels presented a transient decrease at 24. h after lesion. Brain levels of progesterone and DHEA showed a positive correlation with neurological recovery. Plasma analyses showed that progesterone was decreased 72. h after lesion but, in contrast with brain progesterone, its levels did not correlate with neurological deficit. These findings indicate that TBI alters the levels of neuroactive steroids in the brain with independence of its plasma levels and suggest that the pharmacological increase in the brain of the levels of progesterone and DHEA may result in the improvement of neurological recovery after TBI.

Correlation of brain levels of progesterone and dehydroepiandrosterone with neurological recovery after traumatic brain injury in female mice / A.B. Lopez Rodriguez, E. Acaz Fonseca, S. Giatti, D. Caruso, M. Viveros, R.C. Melcangi, L.M. Garcia Segura. - In: PSYCHONEUROENDOCRINOLOGY. - ISSN 0306-4530. - 56(2015), pp. 1-11.

Correlation of brain levels of progesterone and dehydroepiandrosterone with neurological recovery after traumatic brain injury in female mice

S. Giatti;D. Caruso;R.C. Melcangi
Penultimo
;
2015

Abstract

Traumatic brain injury (TBI) is an important cause of disability in humans. Neuroactive steroids, such as progesterone and dehydroepiandrosterone (DHEA), are neuroprotective in TBI models. However in order to design potential neuroprotective strategies based on neuroactive steroids it is important to determine whether its brain levels are altered by TBI. In this study we have used a weight-drop model of TBI in young adult female mice to determine the levels of neuroactive steroids in the brain and plasma at 24. h, 72. h and 2 weeks after injury. We have also analyzed whether the levels of neuroactive steroids after TBI correlated with the neurological score of the animals. TBI caused neurological deficit detectable at 24 and 72. h, which recovered by 2 weeks after injury. Brain levels of progesterone, tetrahydroprogesterone (THP), isopregnanolone and 17β-estradiol were decreased 24. h, 72. h and 2 weeks after TBI. DHEA and brain testosterone levels presented a transient decrease at 24. h after lesion. Brain levels of progesterone and DHEA showed a positive correlation with neurological recovery. Plasma analyses showed that progesterone was decreased 72. h after lesion but, in contrast with brain progesterone, its levels did not correlate with neurological deficit. These findings indicate that TBI alters the levels of neuroactive steroids in the brain with independence of its plasma levels and suggest that the pharmacological increase in the brain of the levels of progesterone and DHEA may result in the improvement of neurological recovery after TBI.
17β-Estradiol; Dehydroepiandrosterone; Isopregnanolone; Progesterone; Testosterone; Tetrahydroprogesterone; Animals; Behavior, Animal; Body Weight; Brain Edema; Brain Injuries; Dehydroepiandrosterone; Estrous Cycle; Female; Mice; Neurotransmitter Agents; Progesterone; Brain Chemistry; Recovery of Function; Endocrinology; Endocrinology, Diabetes and Metabolism; Psychiatry and Mental Health; Biological Psychiatry; Endocrine and Autonomic Systems; Medicine (all)
Settore BIO/10 - Biochimica
Settore MED/13 - Endocrinologia
giu-2015
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0306453015000803-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 2.12 MB
Formato Adobe PDF
2.12 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/432019
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 40
  • ???jsp.display-item.citation.isi??? 39
social impact